Display options
Share it on

Dermatitis. 2021 Nov-Dec 01;32(6):e158-e159. doi: 10.1097/DER.0000000000000775.

Fixed Drug Eruption Induced by Pristinamycin and Amoxicillin-Clavulanic Acid: An Unusual Case of Cosensitization.

Dermatitis : contact, atopic, occupational, drug

Helmi Ammar, Haifa Ben Romdhane, Najeh Ben Fadhel, Zohra Chadli, Naceur A Boughattas, Nadia Ben Fredj, Karim Aouam

PMID: 34405827 DOI: 10.1097/DER.0000000000000775

[No abstract available.]

Conflict of interest statement

The authors have no funding or conflicts of interest to declare.

References

  1. Sánchez-Morillas L, Laguna-Martínez J, Reaño-Martos M, et al. Fixed drug eruption caused by amoxicillin-clavulanic. Ann Allergy Asthma Immunol 2008;101(3):335. - PubMed
  2. El Khoury M, Assier H, Gener G, et al. Polysensitivity in delayed cutaneous adverse drug reactions to macrolides, clindamycin and pristinamycin: clinical history and patch testing. Br J Dermatol 2018;179(4):978–979. - PubMed
  3. Shiohara T, Kokaji T. Polysensitivity in fixed drug eruption. J Am Acad Dermatol 1997;37(6):1017–1018. - PubMed
  4. Ozkaya-Bayazit E. Independent lesions of fixed drug eruption caused by trimethoprim-sulfamethoxazole and tenoxicam in the same patient: a rare case of polysensitivity. J Am Acad Dermatol 2004;51(2 Suppl):S102–S104. - PubMed
  5. Ruocco V, Ruocco E, Piccolo V, et al. The immunocompromised district in dermatology: a unifying pathogenic view of the regional immune dysregulation. Clin Dermatol 2014;32(5):569–576. - PubMed

Publication Types